Navera Investment Management Ltd. decreased its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 14.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 504,636 shares of the semiconductor company’s stock after selling 83,856 shares during the quarter. Synopsys accounts for approximately 4.8% of Navera Investment Management Ltd.’s portfolio, making the stock its 11th largest holding. Navera Investment Management Ltd. owned 0.27% of Synopsys worth $249,105,000 at the end of the most recent reporting period.
Other large investors have also recently made changes to their positions in the company. Evergreen Capital Management LLC grew its position in Synopsys by 68.3% during the third quarter. Evergreen Capital Management LLC now owns 2,651 shares of the semiconductor company’s stock valued at $1,308,000 after buying an additional 1,076 shares during the period. NBT Bank N A NY boosted its stake in shares of Synopsys by 13.4% during the 3rd quarter. NBT Bank N A NY now owns 279 shares of the semiconductor company’s stock worth $138,000 after acquiring an additional 33 shares in the last quarter. ASR Vermogensbeheer N.V. grew its position in shares of Synopsys by 12.0% during the 3rd quarter. ASR Vermogensbeheer N.V. now owns 22,621 shares of the semiconductor company’s stock valued at $11,161,000 after acquiring an additional 2,419 shares during the period. Ritholtz Wealth Management increased its stake in shares of Synopsys by 8.9% in the 3rd quarter. Ritholtz Wealth Management now owns 1,510 shares of the semiconductor company’s stock valued at $745,000 after purchasing an additional 124 shares in the last quarter. Finally, Davis Rea LTD. raised its holdings in Synopsys by 49.9% in the 3rd quarter. Davis Rea LTD. now owns 35,883 shares of the semiconductor company’s stock worth $17,704,000 after purchasing an additional 11,940 shares during the period. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Synopsys Stock Performance
SNPS opened at $516.31 on Friday. The firm has a market capitalization of $98.78 billion, a PE ratio of 64.62, a PEG ratio of 4.30 and a beta of 1.12. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The firm’s 50-day moving average price is $455.35 and its 200 day moving average price is $504.95.
Wall Street Analyst Weigh In
SNPS has been the subject of a number of recent analyst reports. Wall Street Zen upgraded Synopsys from a “sell” rating to a “hold” rating in a research report on Saturday, December 13th. Rosenblatt Securities upgraded shares of Synopsys from a “neutral” rating to a “buy” rating and reduced their price objective for the stock from $605.00 to $560.00 in a research report on Tuesday, December 9th. Piper Sandler lowered shares of Synopsys from an “overweight” rating to a “neutral” rating and dropped their target price for the company from $602.00 to $520.00 in a research report on Tuesday. Wells Fargo & Company boosted their target price on shares of Synopsys from $445.00 to $500.00 and gave the stock an “equal weight” rating in a research note on Thursday, December 11th. Finally, Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and decreased their price target for the company from $525.00 to $500.00 in a research note on Monday, December 8th. Nine equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $553.57.
Check Out Our Latest Report on Synopsys
Insiders Place Their Bets
In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the transaction, the chief financial officer directly owned 17,842 shares in the company, valued at $8,221,058.34. The trade was a 17.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Janet Lee sold 250 shares of the stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. This trade represents a 2.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 4,157 shares of company stock valued at $1,945,036 over the last ninety days. Corporate insiders own 0.62% of the company’s stock.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
- Wall Street Alert: Buy AES
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
